ARCpoint Labs

ARCpoint Labs is a trusted industry leader in the Biotechnology and Health Care sectors, offering a wide range of testing solutions including drug, alcohol, DNA, and clinical testing. Founded in 1998 and headquartered in the United States, ARCpoint Labs has established more than 100 independently owned locations nationwide. The company is dedicated to providing accurate, cost-effective solutions for consumers, businesses, and physicians, and has rapidly emerged as one of the fastest growing third-party administrators for testing solutions.

With a commitment to innovation and expansion, ARCpoint Labs continues to adapt its offerings to better meet the needs of communities, offering businesses a reliable partner for all drug and alcohol testing, policy development, and supervisory training. Additionally, the company provides convenient SARS-CoV-2 testing solutions, aligning with the growing demand for COVID-19 related services.

The latest investment in ARCpoint Labs amounted to $1.10M in Post-IPO Equity, received on 22 January 2024. Although the specific investors for this round are not disclosed, this injection of capital further solidifies the company's position and potential for future growth in the healthcare and biotechnology industries.